Sphygmomanometer Market Size & Share 2025 - 2034

Sphygmomanometer Market Size

The global sphygmomanometer market was valued at USD 5.5 billion in 2024. The market is expected to grow from USD 6 billion in 2025 to USD 11.7 billion in 2034, at a CAGR of 7.8% during the forecast period, according to the latest report published by Global Market Insights Inc. The high market growth is attributed to the rising prevalence of hypertension and cardiovascular diseases, government initiatives promoting preventive healthcare and early diagnosis, and increasing demand for home healthcare and remote patient monitoring, among others.

Sphygmomanometers are diagnostic devices used in clinical medicine, home care, and wellness monitoring, allowing non-invasive and accurate measurement of blood pressure. Leading manufacturers such as Omron, AND, BPL, beurer, and GE Healthcare offer a diverse portfolio of devices, including manual aneroid, digital automatic, and wearable blood pressure monitors. These products incorporate advanced technologies like oscillometric sensors, Bluetooth connectivity, and AI-powered analytics, ensuring high accuracy, ease of use, and seamless integration with electronic health records.
 

The market has increased from USD 4.5 billion in 2021 and reached USD 5.1 billion in 2023, with a historic growth rate of 7%. This was mainly propelled by rising demand for high-quality sphygmomanometers in home healthcare and the growing prevalence of hypertension, increased awareness about regular blood pressure monitoring, and advancements in digital health technologies.
 

With an increasing number of individuals being diagnosed with high blood pressure, often linked to sedentary lifestyles, poor dietary habits, stress, and aging populations, there is a growing emphasis on regular blood pressure monitoring. This has led to heightened demand for reliable and easy-to-use sphygmomanometers, particularly in home healthcare settings. As awareness about the risks associated with uncontrolled hypertension continues to grow, both healthcare providers and consumers are prioritizing early detection and consistent monitoring, thereby fueling market expansion.
 

A sphygmomanometer is a health device used to record blood pressure. It is usually composed of an inflatable cuff encircling the upper arm, a measuring device, and an inflation mechanism, which may be a manual bulb or automatic pump.
 

Sphygmomanometer Market Trends

The technological landscape of the market is evolving rapidly, driven by advancements in various innovative technologies aimed at enhancing the accuracy, convenience, and usability of blood pressure measurement.
 

• One significant trend is the digitalization of sphygmomanometers, which has led to the increased adoption of automated and electronic devices. These digital sphygmomanometers often include features such as memory storage, data tracking, and Bluetooth connectivity, allowing users to monitor their blood pressure over time and share results with healthcare professionals seamlessly.  The incorporation of mobile applications for data analysis and management further enhances patient engagement and compliance, leading to better health outcomes.
   
• Moreover, the integration of wearable technology into blood pressure monitoring. Wearable devices equipped with sensors that measure blood pressure continuously provide real-time insights, promoting proactive management of hypertension. This technology not only eliminates the need for traditional cuff-based methods but also offers user-friendly interfaces, enabling users to track their health metrics conveniently on smartphones.
   
• Additionally, the emergence of telemedicine and remote monitoring solutions is transforming how sphygmomanometry is conducted. As healthcare increasingly shifts toward virtual care, sphygmomanometers that can be used at home and linked to telehealth platforms offer patients the ability to receive professional advice without leaving their homes. This accelerates the adoption of home-based blood pressure monitoring, which is particularly relevant in managing chronic conditions.
   

Sphygmomanometer Market Analysis

Based on the product, the sphygmomanometer market is segmented into digital sphygmomanometer, aneroid sphygmomanometer, and mercury sphygmomanometer. The digital sphygmomanometer segment accounted for 56.7% of the market in 2024 due to its ease of use, higher accuracy, rapid adoption in home healthcare settings, and increasing preference for digital health monitoring solutions among both patients and healthcare professionals. The segment is expected to exceed USD 7 billion by 2034, growing at a CAGR of 8.4% during the forecast period.
 

On the other hand, the aneroid sphygmomanometer segment held a market share of 33.4% in 2024, and its growth can be attributed to its affordability, durability, widespread use in clinical settings, and preference among healthcare professionals for manual blood pressure measurement due to perceived accuracy and reliability.
 

• Digital sphygmomanometers have become more popular due to convenience and portability, ease of use, and their minimal training needs. These devices use oscillometric methods to detect blood pressure with no need to auscultate, which reduces bias from observers. Their ability to link with mobile apps and cloud-based platforms allows for remote monitoring and sharing of data, allowing the use of home and telehealth virtual visit settings.
   
• The mercury sphygmomanometer segment is expected to grow with a 1.6% CAGR during the analysis period. These sphygmomanometers have long been considered the most accurate devices for blood pressure measurement. Their straightforward, gravity-based design yields consistent readings and requires minimal calibration. In many clinical studies and among guidelines, readings obtained using a mercury sphygmomanometer have been the gold standard for comparison and validation.
   

Based on operation, the sphygmomanometer market is segmented into manual, automatic, and semi-automatic. The manual segment dominated the market in 2024 and is growing with a CAGR of 6.3% during the forecast period.
 

• Manual sphygmomanometers, particularly mercury and aneroid types, are widely regarded for their diagnostic precision. They are used in clinical trials and evaluations of higher-risk patients, since they are able to provide accurate auscultation assessments. Even though there are numerous digital devices available, these manual devices continue to be the technology of choice in an environment where accuracy is paramount.
   
• The automatic segment is expected to grow with a 9.1% CAGR during the analysis period. This growth is primarily driven by the increasing demand for user-friendly and accurate blood pressure monitoring devices, the rising prevalence of hypertension, growing adoption of home healthcare solutions, and technological advancements such as Bluetooth connectivity and integration with mobile health apps.
   
• On the other hand, the semi-automatic segment held a market share of 18.2% in 2024, and its growth can be attributed to its cost-effectiveness, ease of operation compared to manual devices, suitability for both clinical and home use, and growing adoption in emerging markets where affordability and basic automation are key considerations.
   

Based on the configuration, the sphygmomanometer market is segmented into portable, desk mounted, floor standing, and wall mounted. The portable segment was anticipated to be worth USD 4.1 billion in 2024 and is expected to grow at an 8% CAGR during the forecast period.
 

• Portable sphygmomanometers are gaining popularity for home and remote patient monitoring, especially among older adults and individuals with chronic diseases. Their small size and simplicity make them more convenient to use and self-measure, aligning with worldwide healthcare trends of decentralization and preventative care.
   
• The desk mounted segment accounted for a 12% share in 2024. The growth is driven due to its robust design, suitability for frequent use in hospitals and clinics, enhanced measurement accuracy, and preference in institutional settings where durability and stability are essential.
   
• The market for the floor standing segment is expected to expand rapidly, driven primarily by the increasing adoption of advanced laboratory testing, rising patient volumes, and the growing need for reliable, contamination-free glassware in clinical diagnostics and pathology labs.
   
• The wall mounted segment is expected to grow with a 6.2% CAGR during the analysis period. This growth is primarily driven by its space-saving design, convenience for frequent blood pressure monitoring in busy clinical environments, enhanced safety and hygiene, and increasing adoption in hospitals and healthcare facilities where wall-mounted devices are preferred for their accessibility and durability.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on end use, the sphygmomanometer market is segmented into hospitals, homecare, ambulatory surgical centers, and other end users. The hospitals segment dominated the market with a revenue share of 44.9% in 2024 and is expected to reach USD 5 billion within the forecast period.
 

• This dominance is primarily attributed to the high volume of patient admissions, increasing prevalence of chronic diseases requiring regular blood pressure monitoring, advanced healthcare infrastructure, and greater adoption of technologically advanced sphygmomanometers in hospital settings.
   
• The homecare segment accounted for a 24.8% share in 2024 and is expected to grow at an 8.6% CAGR. This growth is primarily driven by the rising prevalence of hypertension, increasing awareness of preventive healthcare, growing preference for self-monitoring of blood pressure, and advancements in easy-to-use, portable digital sphygmomanometers designed for home use.
   
• The market for the ambulatory surgical centers segment is expected to expand rapidly, driven primarily by the increasing number of outpatient procedures, rising demand for efficient and accurate blood pressure monitoring in short-stay settings, and the growing preference for minimally invasive surgeries that require reliable perioperative monitoring.
   
• The other end users segment is expected to grow with a 7% CAGR during the analysis period. This growth is primarily driven by its space-saving design, convenience for frequent blood pressure monitoring in busy clinical environments, enhanced safety and hygiene, and increasing adoption in hospitals and healthcare facilities where wall-mounted devices are preferred for their accessibility and durability.
   

North America Sphygmomanometer Market

The North America market is anticipated to grow at a CAGR of 5.3% during the analysis timeframe.
 

• The U.S. sphygmomanometer market was valued at USD 818.3 million and USD 855.5 million in 2021 and 2022, respectively. The market size reached USD 947.1 million in 2024, growing from USD 898 million in 2023, and is anticipated to grow at a CAGR of 5.1% between 2025 to 2034.
   
• North America held a significant market share in the market, supported by its advanced healthcare infrastructure, high prevalence of hypertension, and strong regulatory and clinical validation frameworks. The growth is also driven by widespread awareness of cardiovascular risks and robust FDA approvals.
   
• Additionally, reimbursement and healthcare policy also play a pivotal role. Medicare and private insurers increasingly cover home-use sphygmomanometers, making them more accessible to patients. Value-based care models promoted by CMS and the American Hospital Association encourage accurate monitoring as part of chronic disease management strategies.
   

Europe Sphygmomanometer Market

Europe market accounted for USD 1.3 billion in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• Europe benefits from a well-established healthcare infrastructure and widespread adoption of preventive care practices. Organizations like MedTech Europe, the continent’s leading medical technology association, report increasing investment in digital health solutions, including connected blood pressure monitors that integrate with electronic health records and remote monitoring platforms.
   
• These innovations are particularly relevant in countries with aging populations, such as Germany, France, and Italy, where chronic disease management is a healthcare priority. Additionally, the region’s focus on early diagnosis, chronic disease management, and digital integration will continue to drive demand for advanced blood pressure monitoring solutions.
   

Asia Pacific Sphygmomanometer Market

Asia Pacific dominated the global market with the highest market share of 47.1% in 2024.
 

• Rapid urbanization, increasing prevalence of hypertension, and expanding access to healthcare technologies are contributing factors to the rising growth in this region. According to the Asia-Pacific Legal Metrology Forum (APLMF), the region has prioritized the harmonization, pattern approval, and verification of non-invasive electronic sphygmomanometers, ensuring accuracy and reliability across diverse healthcare systems.
   
• Additionally, countries such as China, India, Japan, and South Korea are investing heavily in healthcare infrastructure and digital health solutions, which is accelerating the adoption of automated and portable blood pressure monitors. The APLMF’s pilot studies and regulatory initiatives have helped establish legal metrology standards for sphygmomanometers, improving confidence in device performance and supporting market growth.
   

Latin America Sphygmomanometer Market

The Latin America market is experiencing robust growth over the analysis timeframe.
 

• Brazil dominated the Latin America sphygmomanometer market. According to the Brazilian Society of Cardiology, approximately 30% of Brazilian adults are affected by hypertension, making blood pressure monitoring a critical component of routine care. This widespread need has driven demand for both clinical-grade and home-use sphygmomanometers across public and private healthcare sectors.
   
• Additionally, Brazil’s commitment to cardiovascular health is reflected in national statistics compiled by the Ministry of Health and the Global Burden of Disease project. Cardiovascular diseases remain the leading cause of death in Brazil, reinforcing the importance of accurate blood pressure monitoring for early detection and management. With ongoing investments in healthcare infrastructure, digital health, and regulatory modernization, Brazil is expected to maintain its dominant position in the Latin American market.
   

Middle East and Africa Sphygmomanometer Market

The Middle East and Africa market is experiencing notable growth over the analysis timeframe.
 

• Saudi Arabia dominated the Latin America market. The Saudi Ministry of Health (MOH) has identified cardiovascular diseases as a major public health concern, with hypertension being one of the most prevalent conditions. This has led to increased demand for both clinical-grade and home-use sphygmomanometers. The country’s healthcare system is undergoing a shift toward outcome-based care models, which emphasize accurate monitoring and patient engagement, further boosting the adoption of validated blood pressure devices.
   
• Additionally, Saudi Arabia’s economic strength and investment in healthcare technology position it as a regional leader. These factors, combined with regulatory modernization and public health initiatives, are expected to sustain Saudi Arabia’s momentum in the market throughout the forecast period.
   

Sphygmomanometer Market Share

Leading industry players such as Omron, AND, beurer, BPL, and GE Healthcare hold around 55% of the market share in the fragmented market. These companies maintain their leadership through robust product portfolios, strong distribution networks, collaborations with healthcare providers, regulatory approvals, and ongoing product innovation. Their dominance is further supported by investments in digital health integration, user-friendly device design, and expansion into emerging markets.
 

Other notable players in the market include BOSCH + SOHN, PRESTIGE MEDICAL, microlife, and rossmax, each contributing to the competitive and fragmented nature of the industry. The market remains dynamic, with technological advancements and increasing demand for home-based and connected blood pressure monitoring solutions shaping the competitive landscape.
 

Sphygmomanometer Market Companies

A few of the prominent players operating in the sphygmomanometer industry include:

• ACCOSON
• ADC
• AND
• beurer
• BOSCH + SOHN
• BPL
• GE Healthcare
• Little Doctor
• microlife
• Omron
• PRESTIGE MEDICAL
• Riester
• rossmax
• Spengler
• SUNTECH
   
• Omron

Omron is recognized as a global leader in the sphygmomanometer market, renowned for its advanced digital blood pressure monitors that combine clinical accuracy with user-friendly design. The company’s strength lies in its continuous innovation, integration of smart health technologies (such as Bluetooth and app connectivity), and a strong focus on preventive healthcare. Omron’s extensive distribution network, robust after-sales support, and commitment to evidence-based product development make it a trusted choice for both home users and healthcare professionals worldwide.
 

• AND

AND Medical differentiates itself through its expertise in precision measurement and sensor technology, delivering highly reliable and accurate sphygmomanometers for both clinical and home use. The company emphasizes seamless data integration, offering devices compatible with telehealth platforms and electronic health records. A&D Medical’s focus on innovation, quality certifications, and global reach ensures its products meet the evolving needs of healthcare providers and patients seeking dependable blood pressure monitoring solutions.
 

• BPL

BPL stands out in the sphygmomanometer market with its legacy of manufacturing robust and affordable blood pressure monitors tailored to diverse healthcare settings. The company’s portfolio includes both digital and aneroid devices, known for their durability, ease of use, and suitability for the Indian and emerging markets. BPL’s commitment to quality, local manufacturing, and responsive customer service, along with its strong presence in hospitals and clinics, reinforces its reputation as a reliable partner in healthcare delivery.
 

Sphygmomanometer Industry News:

• In November 2024, Omron Healthcare announced that it had received De Novo authorization from the U.S. Food and Drug Administration (FDA) for its latest line of blood pressure monitors featuring an AI-powered atrial fibrillation (AFib) detection feature. This may help the company to generate enhanced revenue.
   

The sphygmomanometer market research report includes an in-depth coverage of the industry with estimates and forecasts in terms of revenue in USD Billion and volume in Units from 2021 - 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Digital sphygmomanometer
  • Arm electronic sphygmomanometer
  • Wrist electronic sphygmomanometer
• Aneroid sphygmomanometer
• Mercury sphygmomanometer

Market, By Operation

• Manual
• Automatic
• Semi-automatic

Market, By Configuration

• Portable
• Desk mounted
• Floor standing
• Wall mounted

Market, By End Use

• Hospitals
• Homecare
• Ambulatory surgical centers
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE